288 / 464
288
POSTERS AND ELECTRONIC POSTERS
| Programme and Exhibition Guide
ELECTRONIC POSTERS
> Secondary cancer risk after particle therapy for organs distal or lateral
to the target volume
L. Toussaint (Denmark), L. Muren, G. Engeseth, C. Stokkevåg
EP-1607
> Deriving HPV status from standard CT imaging: a radiomic approach
with independent validation
R. Leijenaar (The Netherlands), M. Nesteruk, G. Feliciani, F. Hoebers,
J. Van Timmeren, W. Van Elmpt, S. Walsh, A. Jochems, S. Huang,
B. Chan, J. Waldron, B. O’Sullivan, D. Rietveld, C. Leemans, O. Riesterer,
K. Ikenberg, P. Lambin
EP-1608
> Tolerance doses for detailed late effects after prostate cancer
radiotherapy – a post-QUANTEC review
C. Olsson (Sweden), M. Thor, J.O. Deasy
EP-1609
> Predictors for morbidity from planned vs. delivered rectal dose maps in
RT of prostate cancer
J. Trane, O. Casares Magaz (Denmark), L. Bentzen, K. Busch, M. Thor,
L.P. Muren
EP-1610
> Dose-response relationships for radiation-induced urgency syndrome
after gynecological radiotherapy
E. Alevronta (Sweden), V. Skokic, U. Wilderäng, G. Dunberger, F. Sjöberg,
C. Bull, K. Bergmark, G. Steineck
EP-1611
> Estimates of the α/β ratio for prostate using data from recent
hypofractionated RT trials.
S. Gulliford (UK), C. Griffin, A. Tree, J. Murray, U. Oelfke, I. Syndikus,
E. Hall, D. Dearnaley
EP-1612
> Modelling DNA damage on gold nanoparticle enhanced proton therapy
M. Sotiropoulos (UK), N.T. Henthorn, J.W. Warmenhoven,
R.I. Mackay, K.J. Kirkby, M.J. Merchant
EP-1613
> Uncertainty of dose-volume constraints obtained from radiation
pneumonitis dose-response analysis
C.M. Lutz (Denmark), D.S. Møller, L. Hoffmann, A.A. Khalil, M.M. Knap,
M. Alber
EP-1614
> Second cancer risk after radiation of localized prostate cancer with and
without flattening filter
M. Treutwein (Germany), M. Hipp, R. Loeschel, O. Koelbl, B. Dobler
EP-1615